Announcements

Home > Investor Relations >Announcements
Back List
Announcement of Key Resolutions of CCSB 2022 Annual General Shareholders' Meeting date : 2022/05/25

SEQ_NO

1

Date of announcement

2022/05/25

Time of announcement

17:21:07

Spokesman:

WANG,KUAN-CHIEH

Title of Spokesman:

Finance Manager

Subject

Announcement of Key Resolutions of CCSB 2022 Annual General Shareholders' Meeting.

To which item it meets

paragraph 18

Date of events

2022/05/25

Statement

1.Date of the shareholders meeting:2022/05/25

2.Important resolutions (1)Profit distribution/ deficit

   compensation:

   Ratification of the distribution of 2021 earnings. Cash dividend to

   shareholders totals NT$100,828,000. (The cash dividend is NT$1.3 per share)

3.Important resolutions (2)Amendments to the corporate charter:

   Approval to amend partial Articles of the Company's Corporate Charter.

4.Important resolutions (3)Business report and financial statements:

   Ratification of the business report and financial statements of 2021.

5.Important resolutions (4)Elections for board of directors and

    supervisors:

   To elect Directors (including independent directors)

   Newly elected Directors

   Representative of CHINA CHEMICAL & PHARMACEUTICAL CO., LTD./

   WANG HSIEH YI-CHEN

   Representative of CHINA CHEMICAL & PHARMACEUTICAL CO., LTD./

   WANG, HOU-KAI

   Representative of WANG MING-NING MEMORIAL FOUNDATION./

   HUANG ,JONG-SHINN

   Representative of WANG MING-NING MEMORIAL FOUNDATION./

   WANG, HOU -JIE

   Newly elected Independent Directors

   WANG ,KUO-CHIANG

   CHANG ,CHIH-HSIEN

   KUAN ARTHUR

6.Important resolutions (5)Any other proposals:

  a.Approval to amend partial Articles of the Regulations Governing

     the Acquisition or Disposal of Assets.

  b.Approval to Intend Private Placement for Issuance of Common

     Stock Shares or Domestic Convertible Corporate Bonds (Including

     Secured or Unsecured Convertible Corporate Bonds).

  c.Approval to release non-compete restrictions on newly elected

     directors and authorized representatives.

7.Any other matters that need to be specified:None